22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
In an important wage-and-hour decision for franchisors, Salazar, et al. v. the McDonald’s Corp., et...
Read More >
I grew up in Brooklyn and the area I originally lived in is called Midwood and I lived right off a s...
Read More >
Last week, in Frlekin v. Apple, Inc., the California Supreme Court held that employee exit searches ...
Read More >
Legislatures across the country are racing to keep up with the ever-expanding uses of artificial int...
Read More >
A judge in the U.S. District Court for the Central District of California recently granted a defenda...
Read More >
State and City Government – General - With limited exceptions, all Philadelphia government buildin...
Read More >